Menu
Peptide Database
Results
No peptides found
Featured

Use search to browse all 100+ peptides

Thymalin

Thymulin, Thymic Factor, Serum Thymic Factor, Facteur Thymique Serique

Quick Stats
Studies 202
Trials 37
Score 2
1989 pubmed

Influence of thymic preparations on the result of experimental infection with Taenia crassiceps (Zeder, 1800) in ICR mice.

Hermánek. J J; Prokopic. J J

Key Findings

  • A single 100 µg subcutaneous dose of Thymalin at infection time reduced cysticerci count by ~55% in mice.
  • Thymalin increased parasite‑specific antibodies, but this increase didn’t correlate with the protective effect.
  • T‑activin alone lowered parasite load by ~54% and restored resistance in mice suppressed with azathioprine.

Practical Outcomes

  • Thymalin shows promise as an immune‑modulating agent that can lower parasite burden in a mouse model, but there’s no direct dosing guidance or evidence for human use. For biohackers, it suggests a potential immune benefit worth watching, yet more human‑focused research is needed before adding it to longevity or health protocols.

Summary

In a mouse study, a single injection of the thymic peptide Thymalin cut the number of Taenia crassiceps parasites in the belly cavity by about half, and a related peptide called T‑activin did the same and even helped mice whose immune systems were weakened by a drug. However, the rise in specific antibodies didn’t explain the protection, and the work was done only in mice with a specific parasite, not in people.

Abstract

Thymalin (Thymarin) and T-activin--thymic preparations of polypeptidic character--were used for influencing the parasitic infection in a model system mouse--Taenia crassiceps. A single subcutaneous application of 100 micrograms of Thymalin per mouse at the day of infection resulted in a decrease (by 54.9%) in the number of cysticerci in peritoneal cavity of experimental mice compared with the controls. Administration of Thymalin with T. crassiceps larval homogenate at various intervals before and after infection resulted in a statistically significant increase of the level of specific antibodies in the serum of infected mice, this increase, however, did not correlate with the corresponding protective effect. Immunosuppressant azathioprine, injected subcutaneously from 7th to 3rd day preceding infection at a dose of 100 micrograms resulted in a significant increase in the number of T. crassiceps larvae in the peritoneal cavity of experimental mice compared with the controls (by 48.7%). T-activin, injected subcutaneously to mice, immunosuppressed by azathioprine, led to a restoration of resistance of mice to T. crassiceps infection. Subcutaneous application of T-activin alone had a significant protective effect (decrease in cysticerci number by 53.7% in comparison with the controls). Correlation of the level of specific antibodies in the serum of infected mice, value of spleen index and number of T. crassiceps cysticerci in peritoneal cavity of mice was not detected.

Study Information

Provider

pubmed

Year

1989